Covid-19 Oral Antivirals In General Practice

COVID-19 oral antivirals in general practice (webinar held 20 June 2022)

North Western Melbourne Primary Health Network

COVID-19 and Oral Antivirals: How to Define an Eligible Patient

New COVID-19 oral antiviral treatments.

Australian Government

Living with COVID: Oral Antiviral Therapies

Oral Antivirals: How to Best Make Use of Their Therapeutic Effects - Giovanni Di Perri, MD, PhD

Academic Medical Education

COVID Oral Antivirals: Is your patient suitable? - 28 February 2022

Case-Based Discussion of Oral Antivirals for COVID-19: Part 1 - Catia Marzolini, PharmD, PhD

Academic Medical Education

COVID treatment trial

E128 – COVID-19 oral antivirals

Australian Prescriber

Case-Based Discussion of Oral Antivirals for COVID-19: Part 2 - Fiona Marra, MPharm, MSc

Academic Medical Education

Advancements in Oral Antiviral Therapy for COVID-19

FDA Media Call: Oral Antiviral Treatments for COVID-19

U.S. Food and Drug Administration

Dr Lucas de Toca - COVID-19 Testing

Australian Department of Health and Aged Care

Doctor discusses antiviral pills for COVID and the rollout of vaccines for kids

Most 'at risk' COVID-19-positive Kiwis to have access to antiviral medicines | Newshub

VV116 for Oral Treatment of Covid-19 | NEJM

GPs Prescribing For COVID-19 In The Community

Capital Health Network

Antiviral Treatment of COVID-19

Superior Health QIO

COVID-19 Update For Clinicians Providing Care And Support To RACF In The ACT

Capital Health Network

Clinical trial produces effective oral antiviral to combat COVID-19

UNC-Chapel Hill